recombinant thermostable trivalent Ebola virus vaccine (University of Hawaii/NIAID/Hawaii Biotech)

N/A

Report date: 2025/01/26 17:50:38

Base Information

Drug Namerecombinant thermostable trivalent Ebola virus vaccine (University of Hawaii/NIAID/Hawaii Biotech)
Drug Alias NameRecombinant Ebola virus vaccine (University of Hawaii/NIAID/Hawaii Biotech)Recombinant Ebola virus vaccine (University of Hawaii/National Institute of Allergy and Infectious Diseases)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Hawaii System
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Hawaii SystemHawaii Biotech IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A